• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

The Charts of Amarin Tell Us That a Close Below $14 Is Key

Let's check the charts of this bio pharmaceutical company that develops drugs for cardiovascular disease.
By BRUCE KAMICH
Mar 04, 2020 | 10:49 AM EST
Stocks quotes in this article: AMRN

During the 'Lightning Round' of the Mad Money program, callers get a chance to ask Jim Cramer about stocks they are interested in. One caller Tuesday night asked about Amarin Corp. (AMRN) : "I liked the quarter and I like the stock here," replied Cramer.  

In this daily bar chart of AMRN, below, we can see that prices have been holding the $14 area. The bigger picture is that prices have been in a wide sideways trading range the past 12 months. Prices are below the declining 50-day moving average line and the flat to declining 200-day moving average line.
 
The daily trading volume histogram below the price chart shows a number of surges or spikes in volume but the On-Balance-Volume (OBV) line shows a decline from August to October, and a decline from December to now. Both of these declines suggest that sellers of AMRN have been more aggressive.
 
The Moving Average Convergence Divergence (MACD) oscillator moved below the zero line in January and it is still bearish.  
 
 
 
In this weekly bar chart of AMRN, below, we can see that prices are in the lower part of a long sideways trading range pattern. Prices are below the declining 40-week moving average line.
 
The weekly OBV line has been weakening since November and tells us that sellers on this time frame have been more aggressive.
 
The MACD oscillator is crossing the zero line for an outright sell signal. 
 
 
In this first Point and Figure chart of AMRN, below, we used daily price data. A long downtrend can be seen and the only positive on this chart is that a downside price target around $17 has been reached.  
 
 
In this second Point and Figure chart of AMRN, below, we used weekly close only price data. Here a downside price target of $6 is indicated but a weekly trade at $14 is needed to weaken the chart.  
 
 
 
Bottom line strategy: I am not sure that AMRN is a good purchase here but I can say that a weekly close below $14 would be a good place to stop out any long positions.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Biotechnology | Healthcare | Pharmaceuticals | Mad Money

More from Investing

You Know What They Say About Dull Markets ...

James "Rev Shark" DePorre
Aug 18, 2022 4:37 PM EDT

Don't short 'em. Let's look at how investors responded to the thin trading and lack of big news -- and what we can expect to come.

With Oil, Keep Your Eyes on the Prize by Focusing on Supply

Jim Collins
Aug 18, 2022 3:59 PM EDT

The earth's oil supply is only going in one direction -- down -- and here's what that means for investors.

I Dislike Blue Apron But Here's a Trade, No Strings Attached

Mark Sebastian
Aug 18, 2022 2:30 PM EDT

The company is never going to make money and is likely heading back below $3 a share.

Europe's Recession Is All About Gas

Maleeha Bengali
Aug 18, 2022 1:30 PM EDT

Prices could very well stay elevated for a long time despite the economy going into a manufacturing recession.

The VIX and SPIKES Have Similarities, But There Are Meaningful Differences

Mark Abssy
Aug 18, 2022 12:00 PM EDT

And if you feel that volatility is an asset class that has a place in your strategy there are 2 funds that may be worth a closer look.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:23 PM EDT STEPHEN GUILFOYLE

    We're Cleaning Out This Retailer From the Bullpen

    Check out the latest moves in TheStreet's Stocks U...
  • 10:24 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    To Improve Your Trading and Investing, Spend More ...
  • 08:44 AM EDT PETER TCHIR

    CPI Beats Expectations, But Maybe Not the 'Whisper'?

    Slightly better-than-expected inflation across the...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login